Nasal Cavity Adenocarcinoma
NCI Definition: An adenocarcinoma that arises from the nasal cavity. It is classified as intestinal-type or non-intestinal-type adenocarcinoma. Nasal obstruction and epistaxis are the presenting symptoms. 
There is 1 clinical trial for nasal cavity adenocarcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains nasal cavity adenocarcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Cisplatin, etoposide, and proton radiation are the most common interventions in nasal cavity adenocarcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.